These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17573817)

  • 1. Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database.
    Buchbinder R; March L; Lassere M; Briggs AM; Portek I; Reid C; Meehan A; Henderson L; Wengier L; van den Haak R
    Intern Med J; 2007 Sep; 37(9):591-600. PubMed ID: 17573817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database.
    Staples MP; March L; Lassere M; Reid C; Buchbinder R
    Rheumatology (Oxford); 2011 Jan; 50(1):166-75. PubMed ID: 20929971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Australian Rheumatology Association Database (ARAD).
    Williams MP; Buchbinder R; March L; Lassere M
    Semin Arthritis Rheum; 2011 Feb; 40(4):e2-3. PubMed ID: 21168188
    [No Abstract]   [Full Text] [Related]  

  • 4. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.
    Chan G; Goh F; Hodgson T; Hsu E; Johnstone D; Ly J; Platt T; Rodrigues E; Tsai W; Hider P; Gray A; Highton J
    N Z Med J; 2008 May; 121(1274):34-41. PubMed ID: 18535644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CORRONA database.
    Kremer JM
    Autoimmun Rev; 2006 Jan; 5(1):46-54. PubMed ID: 16338211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a rheumatology expert nurse on the wellbeing of patients attending a drug monitoring clinic.
    Ryan S; Hassell AB; Lewis M; Farrell A
    J Adv Nurs; 2006 Feb; 53(3):277-86. PubMed ID: 16441532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GISEA: an Italian biological agents registry in rheumatology.
    Lapadula G; Ferraccioli G; Ferri C; Punzi L; Trotta F;
    Reumatismo; 2011 Nov; 63(3):155-64. PubMed ID: 22257916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
    Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
    J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yazici Y; Abramson SB
    Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care provision in pediatric rheumatology in Germany--national rheumatologic database.
    Minden K; Niewerth M; Listing J; Zink A;
    J Rheumatol; 2002 Mar; 29(3):622-8. PubMed ID: 11908581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?
    Edworthy S; Zummer M; Garner S; Boire G; Leclercq S; Bykerk V; Kraag G; Markland J; Thomas D; Thomson J; Henderson J
    J Rheumatol; 2008 Aug; 35(8):1506-12. PubMed ID: 18597407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.
    Adhikesavan LG; Newman ED; Diehl MP; Wood GC; Bili A
    Arthritis Rheum; 2008 Dec; 59(12):1705-12. PubMed ID: 19035412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What matters to patients and physicians when considering biologic therapy for rheumatoid arthritis.
    Lisicki R; Chu L
    Postgrad Med; 2008 Sep; 120(3):154-60. PubMed ID: 18824833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Group for the Respect of Ethics and Excellence in Science (GREES): rheumatoid arthritis section.
    Br J Rheumatol; 1998 Feb; 37(2):211-5. PubMed ID: 9569079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DANBIO--powerful research database and electronic patient record.
    Hetland ML
    Rheumatology (Oxford); 2011 Jan; 50(1):69-77. PubMed ID: 21148154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P; Esselens G; Westhovens R
    Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of standards by the Norwegian Society of Rheumatology. Control of disease modifying drugs].
    Kvien TK; Haga HJ; Kvalvik AG
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2315-8. PubMed ID: 8804206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.